Medical Program: Comparing Combination Therapies for Lung Cancer: Rationales & Risks

Comparing Combination Therapies for Lung Cancer: Rationales & Risks

Comparing Combination Therapies for Lung Cancer: Rationales & Risks
RestartResume

What are some of the benefits versus limitations of combination therapies for our lung cancer patients, and what can we expect on the horizon?

  • Overview

    Here to explain how our refined understandings of driver mutations, immune properties, and tumor microenvironments have changed the way we think about combination therapies, their benefits and limitations, and what’s on the horizon is Dr. Jonathan Riess, Associate Professor of Oncology and Hematology at the UC Davis Medical Center. 

Facebook Comments

NEW FEATURES:

Register

We’re glad to see you’re enjoying Global Oncology Academy…
but how about a more personalized experience?

Register for free